[Alessandro Riberi, oral surgeon].

Minerva Med

Published: October 1967

Download full-text PDF

Source

Publication Analysis

Top Keywords

[alessandro riberi
4
riberi oral
4
oral surgeon]
4
[alessandro
1
oral
1
surgeon]
1

Similar Publications

Seroprevalence of measles antibodies in the Italian general population in 2019-2020.

Vaccine

September 2024

National Coordinator of the Working Group "Vaccines and Immunization Policies", Italian Society of Hygiene, Preventive Medicine and Public Health, Italy.

Article Synopsis
  • Italy has seen a significant drop in measles cases but hasn't yet eliminated the disease, prompting a study on the prevalence of anti-measles antibodies in various demographics.
  • A total of 3746 serum samples from healthy individuals aged 6-64 were analyzed, revealing an overall anti-measles IgG seroprevalence of 91.2%, with higher rates in younger (94.2%) and older (97.6%) age groups.
  • There is notable regional variation in seroprevalence, with higher levels in the South (93.2%) compared to Northern-Central Italy (88.9%), highlighting the need for ongoing vaccination efforts to prevent future outbreaks.
View Article and Find Full Text PDF

Objective: To compare tumor risk in the 4 Beckwith-Wiedemann syndrome (BWS) molecular subgroups: Imprinting Control Region 1 Gain of Methylation (ICR1-GoM), Imprinting Control Region 2 Loss of Methylation (ICR2-LoM), Chromosome 11p15 Paternal Uniparental Disomy (UPD), and Cyclin-Dependent Kinase Inhibitor 1C gene (CDKN1C) mutation.

Study Design: Studies on BWS and tumor development published between 2000 and 2015 providing (epi)genotype-cancer correlations with histotype data were reviewed and meta-analysed with cancer histotypes as measured outcome and (epi)genotype as exposure.

Results: A total of 1370 patients with BWS were included: 102 developed neoplasms (7.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!